Integrated Biopharma, Inc. Appoints Eric Friedman as Director and to the Audit Committee of the Board of Directors
November 09, 2020 at 10:13 pm
Share
On November 4, 2020, Eric Friedman was appointed as a Director of Integrated BioPharma, Inc. to fill the vacancy on the Company's Board of Directors. Mr. Friedman will serve as a Class III Director and his term will expire in 2022. Mr. Friedman has over three decades of accounting and financial operations experience, including controller, chief financial officer and a partner with the accounting firm Shachat & Simpson, CPA's. Mr. Friedman served as the Controller of RES Realty LLC from 2019 to 2020, was an independent consultant from 2016 to 2019 and the Controller of W & E Sales Co. Inc, from 2011 to 2016. Mr. Friedman was also appointed to the Audit Committee of the Board of Directors.
Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Companyâs business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of fine natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.
INTEGRATED BIOPHARMA, INC. 
